Calcium-sensing receptor and renal cation handling.

idiopathic hyperkalemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level. Med J Aust 1968; 2: 1050–1054 5. Arnold JE, Healy JK. Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med 1969; 47: 461–472 6. Mansfield T, Simon D, Farfel Z et al. Multilocus linkage of familial hyperkalemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31–42 and 17p11–q21. Nat Genet 1997; 16: 202–205 7. Disse-Nicodeme S, Achard JM, Desitter I et al. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet 2000; 67: 302–310 8. Disse-Nicodeme S, Desitter I, Fiquet-Kempf B et al. Genetic heterogeneity of familial hyperkalemic hypertension. J Hypertens 2001; 19: 1957–1964 9. Wilson F, Disse-Nicodème S, Choate K et al. Mutations in WNK kinases reveal a novel mechanism of human hypertension. Science 2001; 293: 1107–1112 10. Wilson FH, Kahle KT, Sabath E et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na–Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003; 21; 100: 680–684 11. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na–Cl cotransport. J Clin Invest 2003; 111: 1039–1045 12. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002; 87: 3248–3254 13. Achard JM, Warnock DG, Disse-Nicodeme S et al. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med 2003; 14: 495–498. 14. Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000; 275: 16795–16801 15. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545–556 16. Rossier BC. Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension? J Clin Invest 2003; 111: 947–950 17. Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension 1999; 33: 1324–1331 18. Verissimo F, Jordan P. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 2001; 20: 5562–5569 19. Xu BE, Min X, Stippec S, Lee BH, Goldsmith EJ, Cobb MH. Regulation of WNK1 by an autoinhibitory domain and autophosphorylation. J Biol Chem. 2002; 277: 48456– 48462